Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

Mounjaro (generic name Tirzepatide), developed by Eli Lilly ... Works synergistically with GLP-1 to optimise blood sugar ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

Weight loss drugs like Wegovy, Ozempic, and Mounjaro show transformative effects in obesity, improving heart health and ...